Drug intelligence / Profile preview

4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol

Development stage
Preclinical
Modality
Small Molecules
01

Overview

A synthetic small molecule with the chemical formula C17H13F3N2O2 and a molecular weight of 334.29 g/mol. It is structurally characterized by an indazole core substituted at position 7 with a trifluoromethyl group and at position 3 with a benzene ring bearing two hydroxyl groups (resorcinol moiety), as well as an allyl group at the N^1-position[2][9][10]. This compound has been studied in structural biology for its interaction with estrogen receptors and is referenced as a ligand in crystallographic studies of estrogen receptor-ligand complexes[5]. Its mechanism of action involves binding to the estrogen receptor, likely acting as an agonist or modulator based on its use in ligand selectivity studies[5]. There are no known approved therapeutic indications or marketed products containing this compound; it appears to be used primarily for research purposes.

Other names
4-[1-(prop-2-en-1-yl)-7-(trifluoromethyl)-1H-indazol-3-yl]benzene‑1,3‑diol4-[1-Allyl‑7‑(trifluoromethyl)‑indazol‑3‑yl]-resorcinolCAS 669764–18–5
02

Targets

ER (Estrogen receptor)

Beyond the preview

Go deeper on 4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call